Section Arrow
Quote
LUNG.NASDAQ
- Pulmonx Corp
Quotes are at least 15-min delayed:2026/04/26 08:32 EDT
Regular Hours
Last
 1.27
-0.01 (-0.78%)
Day High 
1.28 
Prev. Close
1.28 
1-M High
1.6 
Volume 
264.91K 
Bid
1.26
Ask
1.3
Day Low
1.2301 
Open
1.27 
1-M Low
1.13 
Market Cap 
54.06M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 1.4 
20-SMA 1.34 
50-SMA 1.46 
52-W High 5.459 
52-W Low 1.13 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.33/-0.56
Enterprise Value
109.11M
Balance Sheet
Book Value Per Share
1.28
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
90.50M
Operating Revenue Per Share
1.53
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
ITOCiTonic Holdings Ltd.0.374+0.0744+24.83%-- 
BSXBoston Scientific Corp62.07-3.62-5.51%33.94PE
ABTAbbott Laboratories91.13-1.35-1.46%24.75PE
EWEdwards Lifesciences Corp84.15+4.43+5.56%45.45PE
PACBPacific Biosciences of California1.56-0.01-0.64%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). solution, which is comprised of the Zephyr Endobronchial Valve (Zephyr Valve), the Chartis Pulmonary Assessment System (Chartis System), and the LungTraX Platform, is designed to treat severe emphysema patients who, despite medical management, are still profoundly symptomatic andeither do not want or are ineligible for surgical approaches. The majority of the company's revenue is generated from the provision of cloud hosting and management services. The company geographically, operates in the USA, the EMEA, the Asia Pacific, and other international regions, the majority of revenue from USA.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.